Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.77 USD | +0.56% | +6.73% | +20.09% |
13/05 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.09% | 154.07Cr | |
+35.01% | 71TCr | |
+30.96% | 60TCr | |
-2.60% | 37TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.42% | 24TCr | |
+9.41% | 21TCr | |
-4.29% | 20TCr | |
+10.77% | 17TCr |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated : Barclays Adjusts Price Target on Ligand Pharmaceuticals to $198 From $146, Reiterates Overweight Rating